Dongsheng Pharmaceutical International Stock Current Valuation
Valuation analysis of Dongsheng Pharmaceutical helps investors to measure Dongsheng Pharmaceutical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Dongsheng Pharmaceutical International Company Current Valuation Analysis
Dongsheng Pharmaceutical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Dongsheng Pharmaceutical Current Valuation | 10.61 K |
Most of Dongsheng Pharmaceutical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dongsheng Pharmaceutical International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Dongsheng Pharmaceutical International has a Current Valuation of 10.61 K. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all United States stocks is notably lower than that of the firm.
Dongsheng Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dongsheng Pharmaceutical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc bb equitys which would be a good addition to a portfolio. Peer analysis of Dongsheng Pharmaceutical could also be used in its relative valuation, which is a method of valuing Dongsheng Pharmaceutical by comparing valuation metrics of similar companies.Dongsheng Pharmaceutical is currently under evaluation in current valuation category among related companies.
Dongsheng Fundamentals
| Return On Equity | 34.37 | |||
| Return On Asset | 14.01 | |||
| Profit Margin | 8.14 % | |||
| Operating Margin | 11.70 % | |||
| Current Valuation | 10.61 K | |||
| Shares Outstanding | 17 M | |||
| Price To Earning | 0.12 X | |||
| Price To Book | 0.03 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 18.22 M | |||
| Gross Profit | 5.31 M | |||
| Net Income | 1.48 M | |||
| Cash And Equivalents | 159.39 K | |||
| Cash Per Share | 0.01 X | |||
| Current Ratio | 2.11 X | |||
| Book Value Per Share | 0.30 X | |||
| Cash Flow From Operations | 999.59 K | |||
| Earnings Per Share | 0.08 X | |||
| Number Of Employees | 69 | |||
| Market Capitalization | 170 K | |||
| Total Asset | 9.7 M | |||
| Retained Earnings | 5.14 M | |||
| Working Capital | 5.04 M | |||
| Current Asset | 9.57 M | |||
| Current Liabilities | 4.53 M | |||
| Z Score | 1.0 |
Pair Trading with Dongsheng Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dongsheng Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dongsheng Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Oracle could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oracle when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oracle - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oracle to buy it.
The correlation of Oracle is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oracle moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oracle moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oracle can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Dongsheng Pharmaceutical information on this page should be used as a complementary analysis to other Dongsheng Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Dongsheng OTC BB Equity
If you are still planning to invest in Dongsheng Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dongsheng Pharmaceutical's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges |